Stay updated on Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page shows a newer system revision label (v3.5.5) replacing the previous v3.5.4, indicating an internal update to the study record history interface.
    Difference
    0.1%
    Check dated 2026-06-02T23:01:02.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    New revision v3.5.4 appears in the study's history. The previous revision v3.5.3 is removed from the list.
    Difference
    0.1%
    Check dated 2026-05-19T15:47:18.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.3) was added to the study's record history, reflecting an update to the record since the previous version.
    Difference
    0.2%
    Check dated 2026-04-28T07:50:20.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.0 to v3.5.2. No study record content or displayed trial information was added or removed.
    Difference
    0.1%
    Check dated 2026-04-21T01:09:25.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0; removed Revision: v3.4.3 from the record history.
    Difference
    0.1%
    Check dated 2026-03-23T04:59:05.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added to the history, and the prior revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-08T23:52:20.000Z thumbnail image

Stay in the know with updates to Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib+Capecitabine in Trastuzumab-Resistant Breast Cancer Clinical Trial page.